Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 3,941 - 3,960 results of 14,357 for search '(( significantly ((larger decrease) OR (mean decrease)) ) OR ( significantly increased decrease ))', query time: 0.70s Refine Results
  1. 3941
    Cox proportional hazard ratios.

    Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3942
    Liver samples were stained with hematoxylin and eosin and imaged at 4x.

    Liver samples were stained with hematoxylin and eosin and imaged at 4x. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3943
    Bioluminescent Doubling Time.

    Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 3944
    Study Design.

    Study Design. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 3945
    Histomorphometric analysis of the tumor volume fraction (V<sub>f</sub>) in the liver and necrosis volume fraction.

    Histomorphometric analysis of the tumor volume fraction (V<sub>f</sub>) in the liver and necrosis volume fraction. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 3946
    (A) Release rate (i.e., elution) of N-allyl noroxymorphone hydrochloride evaluated using UPLC from two samples of MBC-005. The equations predict that at 24-hours there will be between 0.798-mg and 1.205-mg of N-allyl noroxymorphone hydrochloride remaining. (B) Contour plot showing N-allyl noroxymorphone hydrochloride elution using different compositions of MBC-005. The contour plot generated predicts an optimal elution rate at 24-hours of 0.14647-mg/hr<sup>1/2</sup>.

    (A) Release rate (i.e., elution) of N-allyl noroxymorphone hydrochloride evaluated using UPLC from two samples of MBC-005. The equations predict that at 24-hours there will be betw... by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3947
    The MTT assay and the LDH assay were used to assess the effects of the hydrogel component of MBC-005 on tumor cell number and cell death.

    The MTT assay and the LDH assay were used to assess the effects of the hydrogel component of MBC-005 on tumor cell number and cell death. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3948
    The spheroid assay is used to assess long-term effects of therapy on tumor cell by culturing the tumor cells in a micro-mass, which is a 3D tumor mass used as a surrogate for in vivo tumor cell growth dynamics.

    The spheroid assay is used to assess long-term effects of therapy on tumor cell by culturing the tumor cells in a micro-mass, which is a 3D tumor mass used as a surrogate for in vi... by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3949
    Survival in mice with liver metastases after MBC-005 TREATMENT.

    Survival in mice with liver metastases after MBC-005 TREATMENT. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 3950
    Viscosity assessed using a tuning-fork viscometer.

    Viscosity assessed using a tuning-fork viscometer. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 3951
    Interpolated survival in mice with or without lung metastases.

    Interpolated survival in mice with or without lung metastases. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3952
    The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21.

    The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 3953
    Schematic representation of G<sub>1</sub> cell cycle arrest inhibited by CsA in gingival fibroblasts.

    Schematic representation of G<sub>1</sub> cell cycle arrest inhibited by CsA in gingival fibroblasts. by Reiri Takeuchi (20460788)

    Published 2024
    Save to List
    Saved in:
  14. 3954
    Expression of M1 and M2 surface markers in alveolar macrophages of MH-S cell line stimulated with SMPs.

    Expression of M1 and M2 surface markers in alveolar macrophages of MH-S cell line stimulated with SMPs. by Alejandra Barrera-Rosales (21656278)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 3955
    Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by Transmission Electron Microscopy (TEM).

    Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by Transmission Electron Microscopy (TEM). by Alejandra Barrera-Rosales (21656278)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 3956
    Raw data underlying figures 1–7.

    Raw data underlying figures 1–7. by Alejandra Barrera-Rosales (21656278)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 3957
    Opioid consumption data.

    Opioid consumption data. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
    Save to List
    Saved in:
  18. 3958
    Prescription data.

    Prescription data. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
    Save to List
    Saved in:
  19. 3959
    Refill rate by surgical specialty.

    Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
    Save to List
    Saved in:
  20. 3960
    Noncontinuous data on opioid use.

    Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
    Save to List
    Saved in:

Search Tools: